As of 2025-07-06, the Intrinsic Value of Xebio Holdings Co Ltd (8281.T) is 698.03 JPY. This 8281.T valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,102.00 JPY, the upside of Xebio Holdings Co Ltd is -36.70%.
The range of the Intrinsic Value is 478.63 - 4,053.09 JPY
Based on its market price of 1,102.00 JPY and our intrinsic valuation, Xebio Holdings Co Ltd (8281.T) is overvalued by 36.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 478.63 - 4,053.09 | 698.03 | -36.7% |
| DCF (Growth 10y) | 139.73 - (1,839.79) | 19.19 | -98.3% |
| DCF (EBITDA 5y) | 908.19 - 1,286.16 | 1,129.04 | 2.5% |
| DCF (EBITDA 10y) | 798.65 - 1,199.84 | 1,018.49 | -7.6% |
| Fair Value | 506.68 - 506.68 | 506.68 | -54.02% |
| P/E | 287.39 - 839.54 | 467.82 | -57.5% |
| EV/EBITDA | 1,134.54 - 1,774.16 | 1,398.49 | 26.9% |
| EPV | 2,227.44 - 3,127.89 | 2,677.67 | 143.0% |
| DDM - Stable | 332.93 - 4,047.39 | 2,190.15 | 98.7% |
| DDM - Multi | 1,034.86 - 8,508.71 | 1,752.07 | 59.0% |
| Market Cap (mil) | 52,796.82 |
| Beta | 0.31 |
| Outstanding shares (mil) | 47.91 |
| Enterprise Value (mil) | 40,307.82 |
| Market risk premium | 6.13% |
| Cost of Equity | 5.65% |
| Cost of Debt | 4.25% |
| WACC | 5.32% |